Clinical Trials Directory

Trials / Completed

CompletedNCT04185740

Medication Responsiveness in Parkinson's Disease

The Stability in Medication Responsiveness During Research Experiments in Parkinson's Disease

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
33 (actual)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Up till now, dopaminergic replacement is considered as the gold standard for the symptomatic treatment of motor symptoms in Parkinson's disease (PD). However, the intake, especially higher doses when taken for a longer duration, are associated with several side effects including response fluctuations. These fluctuations in medication response are often characterized by a wearing-OFF period, also defined as the recurrence of PD symptoms before a patient should take the next dose of medication. The duration of test sessions during research experiments (e.g. in the field of rehabilitation) can interfere with the period of the optimal therapeutic effect of dopaminergic medication, influencing outcomes of a study. Therefore, the objective of this project is to get more insight in the measurability of ON-OFF fluctuations by testing the applicability of a short and simple timed tapping task (TTT) on a smartphone in rehabilitation research studies. The assessment can be useful for future clinical studies in PD where a precise estimation of medication is indispensable for accurate research outcomes.

Conditions

Interventions

TypeNameDescription
DEVICECloudUPDRS - Tapping TaskThe TTT, consisting of two targets, will be presented on the screen of the smartphone. Participants will be instructed to alternate between the two targets using their index finger for 30 seconds. The task will always be performed with the left hand first and then with the right hand. The touch-sensitive screen of the smartphone will measure the timing of each touch event, its duration, the coordinates on the phone screen and the amount of pressure applied.

Timeline

Start date
2019-07-25
Primary completion
2020-10-20
Completion
2020-10-20
First posted
2019-12-04
Last updated
2021-01-27

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04185740. Inclusion in this directory is not an endorsement.